Bacterial Infections

Resource Center

FDA Alerts

Treatment

FDA Approves Ready-To-Use Antibacterial Injection

06/08/2017

The US Food and Drug Administration has approved 3 formulations of a commonly prescribed antibiotic in injection form.

06/08/2017

Research Summaries

Research Summary

AGA Recommends Fecal Microbiota Transplant in Some Adults With Recurrent C difficile Infection

07/02/2024

Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...

07/02/2024

Research Summary

Task Force Develops, Validates New Criteria for Diagnosing Pediatric Sepsis and Septic Shock

04/05/2024

Anthony Calabro, MA

An international task force of 35 pediatric experts developed and validated new criteria for sepsis and septic shock in children and adolescents based on a large international database and a systematic...

04/05/2024

FDA Alert

First Oral Treatment to Prevent Recurring Clostridioides difficile Infection Approved

06/01/2023

Jessica Ganga

The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.

06/01/2023

Research Summary

Sepsis Increases Risk of Post-Discharge Cardiovascular Events, Death

02/24/2023

Researchers sought to determine whether adults hospitalized for sepsis are at an increased risk of death or rehospitalization for cardiovascular events.

02/24/2023

Disease Prevention

FDA Approves Fecal Microbiota Product For Clostridioides difficle Infection Prevention

12/13/2022

Following three studies that examined its safety and efficacy, the FDA approves the first fecal microbiota product to prevent recurring Clostridioides difficle infection in patients.

12/13/2022

September 2024

Current Issue

September 2024

Volume 64

Issue 9